logo

For the Inventor, By the Inventor

Seoul, South Korea

Toolgen Inc.


USPTO Granted Patents = 17



Trademarks = 3

Forward Citations = 56

Loading Chart...
Loading Chart...

42 inventors (with patents filed for the assignee):

goldMedal Seok Joong Kim (6 out of 28 patents)

silverMedal Jung Min Lee (6 out of 53 patents)

bronzeMedal Dong Woo Song (6 out of 6 patents)

4.  Seokjoong Kim (5 out of 7 patents)

5.  Min Hee Jung (3 out of 3 patents)

6.  Jae Young Lee (3 out of 54 patents)

7.  Yoon-young Kim (2 out of 6 patents)

8.  Jin-Soo Kim (2 out of 149 patents)

9.  Gyu-bon Cho (2 out of 2 patents)

10.  Jeong Hun Kim (2 out of 46 patents)

11.  Hee Sook Bae (2 out of 2 patents)

12.  Ho-Sung Yu (2 out of 2 patents)

13.  In-Young Jung (2 out of 2 patents)

14.  Dong Hyun Jo (1 out of 7 patents)

15.  Sojung Kim (1 out of 4 patents)


17 patents:

1. 12351838 - Target-specific CRISPR mutant (2025-07-08),
2. 12331086 - Artificially engineered SC function control system (2025-06-17),
3. 12286635 - Oleic acid-enriched plant body having genetically modified FAD2 and production method thereof (2025-04-29),
4. 12275963 - Artificially manipulated immune cell (2025-04-14),
5. 12241071 - Composition for editing flavonoid biosynthetic gene by using CRISPR/Cas9 system, and use thereof (2025-03-04),
6. 12163149 - Artificial genome manipulation for gene expression regulation (2024-12-10),
7. 12012598 - Manipulated immunoregulatory element and immunity altered thereby (2024-06-18),
8. 11999952 - Artificially-manipulated neovascularization regulatory system (2024-06-04),
9. 11920151 - Method for identifying DNA base editing by means of cytosine deaminase (2024-03-05),
10. 11845951 - Gene manipulation for treatment of retinal dysfunction disorder (2023-12-19),
11. 11667934 - Platform for expressing protein of interest in liver (2023-06-06),
12. 11572574 - Artificial genome manipulation for gene expression regulation (2023-02-07),
13. 11441135 - Target-specific CRISPR mutant (2022-09-13),
14. 10851380 - Methods for cleaving a target DNA using a guide RNA specific for the target DNA and Cas protein-encoding nucleic acid or Cas protein (2020-12-01),
15. 10519454 - Genome editing usingCRISPR/CAS system-derived RGEN (2019-12-31),
Toolgen Inc. is a biotechnology company specializing in gene editing technologies. The company's innovative tools enable precise and efficient genome editing for a wide range of applications, from agriculture to human therapeutics. With a talented team of scientists and cutting-edge research facilities, Toolgen is at the forefront of the gene editing revolution.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

17 Patents

#218 in Seoul

#681 in South Korea

#34,861 in the World

...
Seoul, South Korea

Toolgen Inc.

Forward Citations = 56

42 inventors:

goldMedal Seok Joong Kim (6 out of 28 patents)

silverMedal Jung Min Lee (6 out of 53 patents)

bronzeMedal Dong Woo Song (6 out of 6 patents)

4.  Seokjoong Kim (5 out of 7 patents)

5.  Min Hee Jung (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com
Loading…